These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14014522)

  • 1. [The treatment of the myeloproliferative syndromes].
    BOUSSER J; ALIZON M
    Sem Hop Ther Paris; 1963 Mar; 39():161-6. PubMed ID: 14014522
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycythaemia, myelofibrosis. Splenectomy, myeloid leukosis and polycythaemia.
    ASHER R
    Proc R Soc Med; 1955 Jul; 48(7):539-40. PubMed ID: 13245824
    [No Abstract]   [Full Text] [Related]  

  • 3. [POLYCYTHEMIA AND MYELOSCLEROSIS].
    OLIVA G; SILVESTRI G; PUGLIESE F
    Minerva Med; 1963 Dec; 54():3885-91. PubMed ID: 14121443
    [No Abstract]   [Full Text] [Related]  

  • 4. MYLERAN AS A THERAPEUTIC ADJUNCT IN GASTROINTESTINAL BLEEDING COMPLICATING MYELOPROLIFERATIVE DISORDERS.
    BRODY JI; MCKENZIE D; KIMBALL SG
    Gastroenterology; 1963 Oct; 45():499-504. PubMed ID: 14070423
    [No Abstract]   [Full Text] [Related]  

  • 5. [Megakaryocytic splenomegaly within the framework of myeloproliferative diseases (on the basis of 4 cases)].
    Brunetti L
    Arch De Vecchi Anat Patol; 1967 Aug; 49(2):619-46. PubMed ID: 5608914
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic splenomegaly in polycythemia vera: a review of the indications for splenectomy and perioperative considerations.
    Logan MS; Watson CM; Nottingham JM
    Am Surg; 2009 May; 75(5):363-8. PubMed ID: 19445284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of cirrhosis of a rare kind].
    Cacciari C; Abate L; Soverini A
    J Commun; 1969 Sep; 19(3):185-9. PubMed ID: 4242162
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of cirrhosis of a rare kind].
    Cacciari C; Abate L; Soverini A
    Respiration; 1969; 26():185-9. PubMed ID: 4245502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
    Dupriez B; Demory JL
    Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy in leukemia and myelofibrosis. Changes in the erythrocyte values.
    STRUMIA MM; DUGAN A; TAYLOR L; STRUMIA PV; BASSERT D
    Am J Clin Pathol; 1962 May; 37():491-8. PubMed ID: 13917893
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
    Hasselbalch HC
    Leuk Res; 2009 Jan; 33(1):11-8. PubMed ID: 18632152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On 2 cases of myeloid splenomegaly with osteomyelosclerosis terminating in malignant reticular transformation].
    MARCHAL G; DUHAMEL G; PERLES S
    Bull Mem Soc Med Hop Paris; 1962; 113():619-25. PubMed ID: 14469607
    [No Abstract]   [Full Text] [Related]  

  • 17. Subtotal splenectomy in myelofibrosis.
    Morgenstern L; Kahn FH; Weinstein IM
    Surgery; 1966 Aug; 60(2):336-9. PubMed ID: 5915462
    [No Abstract]   [Full Text] [Related]  

  • 18. A transmissible disease of mice characterized by anemia, leukopenia, splenomegaly and myelosclerosis.
    UPTON AC; FURTH J
    Acta Haematol; 1955 Feb; 13(2):65-76. PubMed ID: 14361093
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for splenomegaly.
    Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
    JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.